跳至主要内容
临床试验/CTRI/2013/09/003954
CTRI/2013/09/003954尚未招募未知

Influence of genetic polymorphism of CYP2C19 on pharmacokinetics and pharmacodynamics of clopidogrel therapy in Indian population

Indian Council of Medical Research0 个研究点目标入组 120 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Patients who are diagnosed with cardiovascular indications requiring treatment with clopidogrel as anti-platelet therapy.
  • 2. Patients who are newly started on clopidogrel therapy and will be visiting cardiology department for follow-up.

排除标准

  • 1.Clinically unstable patients
  • 2.Patients who are already stabilized with clopidogrel monotherapy or combination therapy with aspirin

研究者

相似试验